- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.82 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x U5P: URIDINE-5'-MONOPHOSPHATE(Non-covalent)
- 6 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
TRS.2: 3 residues within 4Å:- Chain A: F.67, E.68, D.115
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:E.68, A:E.68
TRS.12: 7 residues within 4Å:- Chain B: F.67, E.68, W.82, D.115
- Chain F: E.290
- Ligands: FMT.20, EDO.21
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.68
- Water bridges: B:W.110, B:D.115
TRS.23: 3 residues within 4Å:- Chain C: F.67, E.68, D.115
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:E.68, C:E.68
TRS.33: 7 residues within 4Å:- Chain B: E.290
- Chain D: F.67, E.68, W.82, D.115
- Ligands: FMT.41, EDO.42
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:E.68
- Water bridges: D:W.110, D:D.115
TRS.44: 3 residues within 4Å:- Chain E: F.67, E.68, D.115
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:E.68, E:E.68
TRS.54: 7 residues within 4Å:- Chain D: E.290
- Chain F: F.67, E.68, W.82, D.115
- Ligands: FMT.62, EDO.63
3 PLIP interactions:3 interactions with chain F- Hydrogen bonds: F:E.68
- Water bridges: F:W.110, F:D.115
- 30 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 8 residues within 4Å:- Chain A: N.76, E.80, C.126, S.127, M.128
- Chain D: E.27, P.47, V.48
Ligand excluded by PLIPEDO.5: 3 residues within 4Å:- Chain A: N.223, L.224, Y.302
Ligand excluded by PLIPEDO.6: 5 residues within 4Å:- Chain A: N.97, G.100, V.101, D.102
- Chain E: D.60
Ligand excluded by PLIPEDO.7: 8 residues within 4Å:- Chain A: L.335, S.336, V.337, V.338, C.357, K.358, D.359, G.360
Ligand excluded by PLIPEDO.8: 7 residues within 4Å:- Chain A: E.92, V.93, W.110, Y.112, K.113, S.185, D.296
Ligand excluded by PLIPEDO.9: 5 residues within 4Å:- Chain A: N.98, L.99, G.100, K.204, Y.348
Ligand excluded by PLIPEDO.13: 3 residues within 4Å:- Chain B: V.172, K.173, G.174
Ligand excluded by PLIPEDO.14: 5 residues within 4Å:- Chain B: S.178, V.179, E.215, T.216, F.218
Ligand excluded by PLIPEDO.16: 4 residues within 4Å:- Chain B: E.215, K.343, T.345, E.350
Ligand excluded by PLIPEDO.21: 3 residues within 4Å:- Chain B: E.68
- Ligands: TRS.12, FMT.20
Ligand excluded by PLIPEDO.24: 8 residues within 4Å:- Chain C: N.76, E.80, C.126, S.127, M.128
- Chain F: E.27, P.47, V.48
Ligand excluded by PLIPEDO.26: 3 residues within 4Å:- Chain C: N.223, L.224, Y.302
Ligand excluded by PLIPEDO.27: 5 residues within 4Å:- Chain A: D.60
- Chain C: N.97, G.100, V.101, D.102
Ligand excluded by PLIPEDO.28: 8 residues within 4Å:- Chain C: L.335, S.336, V.337, V.338, C.357, K.358, D.359, G.360
Ligand excluded by PLIPEDO.29: 7 residues within 4Å:- Chain C: E.92, V.93, W.110, Y.112, K.113, S.185, D.296
Ligand excluded by PLIPEDO.30: 5 residues within 4Å:- Chain C: N.98, L.99, G.100, K.204, Y.348
Ligand excluded by PLIPEDO.34: 3 residues within 4Å:- Chain D: V.172, K.173, G.174
Ligand excluded by PLIPEDO.35: 5 residues within 4Å:- Chain D: S.178, V.179, E.215, T.216, F.218
Ligand excluded by PLIPEDO.37: 4 residues within 4Å:- Chain D: E.215, K.343, T.345, E.350
Ligand excluded by PLIPEDO.42: 3 residues within 4Å:- Chain D: E.68
- Ligands: TRS.33, FMT.41
Ligand excluded by PLIPEDO.45: 8 residues within 4Å:- Chain B: E.27, P.47, V.48
- Chain E: N.76, E.80, C.126, S.127, M.128
Ligand excluded by PLIPEDO.47: 3 residues within 4Å:- Chain E: N.223, L.224, Y.302
Ligand excluded by PLIPEDO.48: 5 residues within 4Å:- Chain C: D.60
- Chain E: N.97, G.100, V.101, D.102
Ligand excluded by PLIPEDO.49: 8 residues within 4Å:- Chain E: L.335, S.336, V.337, V.338, C.357, K.358, D.359, G.360
Ligand excluded by PLIPEDO.50: 7 residues within 4Å:- Chain E: E.92, V.93, W.110, Y.112, K.113, S.185, D.296
Ligand excluded by PLIPEDO.51: 5 residues within 4Å:- Chain E: N.98, L.99, G.100, K.204, Y.348
Ligand excluded by PLIPEDO.55: 3 residues within 4Å:- Chain F: V.172, K.173, G.174
Ligand excluded by PLIPEDO.56: 5 residues within 4Å:- Chain F: S.178, V.179, E.215, T.216, F.218
Ligand excluded by PLIPEDO.58: 4 residues within 4Å:- Chain F: E.215, K.343, T.345, E.350
Ligand excluded by PLIPEDO.63: 3 residues within 4Å:- Chain F: E.68
- Ligands: TRS.54, FMT.62
Ligand excluded by PLIP- 12 x ACT: ACETATE ION(Non-functional Binders)
ACT.4: 2 residues within 4Å:- Chain A: W.356, E.363
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.356
- Hydrogen bonds: A:E.363
ACT.15: 8 residues within 4Å:- Chain B: L.335, S.336, V.337, V.338, C.357, K.358, D.359, G.360
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:D.359, B:G.360
ACT.17: 5 residues within 4Å:- Chain B: E.169, K.197, Q.199, F.200, N.201
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:Q.199
- Hydrogen bonds: B:Q.199, B:N.201
- Salt bridges: B:K.197
ACT.18: 7 residues within 4Å:- Chain B: G.149, V.155, T.168, E.169, G.170, S.171, V.172
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:V.155, B:T.168
- Hydrogen bonds: B:E.169, B:G.170
ACT.25: 2 residues within 4Å:- Chain C: W.356, E.363
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:W.356
- Hydrogen bonds: C:E.363
ACT.36: 8 residues within 4Å:- Chain D: L.335, S.336, V.337, V.338, C.357, K.358, D.359, G.360
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:D.359, D:G.360
ACT.38: 5 residues within 4Å:- Chain D: E.169, K.197, Q.199, F.200, N.201
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:Q.199
- Hydrogen bonds: D:Q.199, D:N.201
- Salt bridges: D:K.197
ACT.39: 7 residues within 4Å:- Chain D: G.149, V.155, T.168, E.169, G.170, S.171, V.172
4 PLIP interactions:4 interactions with chain D- Hydrophobic interactions: D:V.155, D:T.168
- Hydrogen bonds: D:E.169, D:G.170
ACT.46: 2 residues within 4Å:- Chain E: W.356, E.363
2 PLIP interactions:2 interactions with chain E- Hydrophobic interactions: E:W.356
- Hydrogen bonds: E:E.363
ACT.57: 8 residues within 4Å:- Chain F: L.335, S.336, V.337, V.338, C.357, K.358, D.359, G.360
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:D.359, F:G.360
ACT.59: 5 residues within 4Å:- Chain F: E.169, K.197, Q.199, F.200, N.201
4 PLIP interactions:4 interactions with chain F- Hydrophobic interactions: F:Q.199
- Hydrogen bonds: F:Q.199, F:N.201
- Salt bridges: F:K.197
ACT.60: 7 residues within 4Å:- Chain F: G.149, V.155, T.168, E.169, G.170, S.171, V.172
4 PLIP interactions:4 interactions with chain F- Hydrophobic interactions: F:V.155, F:T.168
- Hydrogen bonds: F:E.169, F:G.170
- 3 x SO4: SULFATE ION(Non-functional Binders)
SO4.10: 5 residues within 4Å:- Chain A: E.252, G.253, Y.254, G.360, H.361
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Y.254
- Water bridges: A:G.360
- Salt bridges: A:H.361
SO4.31: 5 residues within 4Å:- Chain C: E.252, G.253, Y.254, G.360, H.361
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:Y.254
- Water bridges: C:G.360
- Salt bridges: C:H.361
SO4.52: 5 residues within 4Å:- Chain E: E.252, G.253, Y.254, G.360, H.361
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:Y.254
- Water bridges: E:G.360
- Salt bridges: E:H.361
- 6 x FMT: FORMIC ACID(Non-functional Binders)
FMT.19: 4 residues within 4Å:- Chain B: K.70, K.113, R.114
- Chain D: E.65
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:K.70, B:K.70
FMT.20: 3 residues within 4Å:- Chain B: D.115
- Ligands: TRS.12, EDO.21
1 PLIP interactions:1 interactions with chain B- Water bridges: B:Y.112
FMT.40: 4 residues within 4Å:- Chain D: K.70, K.113, R.114
- Chain F: E.65
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:K.70, D:K.70
FMT.41: 3 residues within 4Å:- Chain D: D.115
- Ligands: TRS.33, EDO.42
1 PLIP interactions:1 interactions with chain D- Water bridges: D:Y.112
FMT.61: 4 residues within 4Å:- Chain B: E.65
- Chain F: K.70, K.113, R.114
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:K.70, F:K.70
FMT.62: 3 residues within 4Å:- Chain F: D.115
- Ligands: TRS.54, EDO.63
1 PLIP interactions:1 interactions with chain F- Water bridges: F:Y.112
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kim, Y. et al., Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2. Commun Biol (2021)
- Release Date
- 2020-04-29
- Peptides
- Uridylate-specific endoribonuclease: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.82 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x U5P: URIDINE-5'-MONOPHOSPHATE(Non-covalent)
- 6 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 30 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 12 x ACT: ACETATE ION(Non-functional Binders)
- 3 x SO4: SULFATE ION(Non-functional Binders)
- 6 x FMT: FORMIC ACID(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kim, Y. et al., Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2. Commun Biol (2021)
- Release Date
- 2020-04-29
- Peptides
- Uridylate-specific endoribonuclease: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
B